Ill. 'Innovator Liability' Case Is Setback For Drug Cos.
March 14, 2014, 3:39 PM EDT
Law360, New York (March 14, 2014, 3:39 PM EDT) -- A federal district court in Illinois recently held that GlaxoSmithKline PLC, a branded drug manufacturer, owed a duty of care to a patient who took the generic version of its drug. Dolin v. SmithKline Beecham Corp. (2014). This holding is a surprising deviation from the current trend, as most courts have held that “innovator liability” does not apply where plaintiff claimed injury from taking the generic product.
The plaintiff, Wendy Dolin, is the widow of Stewart Dolin, who was an M&A partner at Reed Smith LLP...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.